Researchers develop new computational tool to interpret clinical significance of cancer mutations
Women, low earners ‘prone to disaster-linked depression’
6 May 2022CDC probing 109 liver illnesses in kids, including 5 deaths
6 May 2022Researchers develop new computational tool to interpret clinical significance of cancer mutations
Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret the clinical significance of somatic mutations in cancer. The tool, known as CancerVar, incorporates machine learning frameworks to go beyond merely identifying somatic cancer mutations and interpret the potential significance of those mutations in terms of cancer diagnosis, prognosis, and targetability. A paper describing CancerVar was published today in Science Advances.
